Pemetrexed Plus Gemcitabine in Metastatic Breast Cancer Patients After Receiving Taxane Therapy
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer|Breast Neoplasms
Interventions: DRUG: Pemetrexed|DRUG: Gemcitabine|DRUG: Gemcitabine|DRUG: Pemetrexed
Sponsor: Eli Lilly and Company